Advertise on podcast: Decera Clinical Education Neuroscience Podcast

The introduction of muscarinic receptor agonism offers a new approach to schizophrenia treatment beyond traditional dopamine D2 receptor blockade. Listen in while Rebecca DePalma, DMSc, PA-C, explores the rationale behind targeting this new mechanism and emerging evidence for muscarinic therapies, with a focus on xanomeline/trospium. Through a discussion of efficacy, safety, and practical prescribing considerations, find out how these advances may apply to your practice and improve patient-centered care. Presenter:Rebecca DePalma, DMSc, PA-C​Psychiatric Physician Associate​Doctorate of Medical Science​Adjunct Clinical Faculty, Pacific University​Co-Author of First Line Guide: Psychiatric and ​Behavioral Medicine​Seattle, Washington Link to full program:https://bit.ly/4gvLZYm Get access to all of our new podcasts by subscribing to the Decera Clinical Education Neuroscience Podcast on Apple Podcasts, YouTube Music, or Spotify.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Effective acute pain management requires balancing adequate pain relief with the risks and limitations of available analgesics. Listen in as Mitchell P. Engle, MD, PhD; Kathy Kates, FNP-BC; Michael Sprintz, DO, DFASAM; and Amanda Zimmerman, PA-C, explore emerging non-opioid treatment options, including selective NaV1.8 inhibition with suzetrigine, and the role of multimodal analgesia in acute pain management to find out how to expand your pain tool kit and improve patient-centered care. Presenters: Mitchell P. Engle, MD, PhDScientific and Medical ConsultantPartner, Institute of Precision Pain Medicine​Corpus Christi, Texas​ Kathy Kates, FNP-BCCEOPelvic Health Support​Brookline, Massachusetts​ Michael Sprintz, DO, DFASAMMedical Director, Substance Abuse and Mental Health IOP Programs​The Lovett Behavioral Health Group​Houston, Texas​ Amanda Zimmerman, PA-CWest Forsyth Pain Management​Winston-Salem, North Carolina​ Link to full program:https://bit.ly/4swPrGL Get access to all of our new podcasts by subscribing to the Decera Clinical Education Neuroscience Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Emerging therapies are reshaping schizophrenia care by introducing novel mechanisms that extend beyond traditional dopamine receptor blockade. Listen in to learn from Dr Leslie Citrome about evolving concepts in schizophrenia neurobiology; the clinical evidence supporting emerging therapeutic approaches with a focus on muscarinic-targeted therapies; and practical strategies for translating these advances into patient care, including treatment selection, safety, and tolerability considerations. Presenter:Leslie Citrome, MD, MPH Clinical Professor, Psychiatry and Behavioral Sciences New York Medical College Valhalla, New York Adjunct Professor, Psychiatry and Behavioral Sciences Northwestern Feinberg School of Medicine Chicago, Illinois Link to full program:https://bit.ly/4gvLZYm Get access to all of our new podcasts by subscribing to the Decera Clinical Education Neuroscience Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Novel C5 inhibitors are reshaping individualized care for generalized myasthenia gravis. Listen in to learn from Drs Muppidi, Narayanaswami, Kaminski, and Paul about persistent needs in gMG care, clinical differences among C5 inhibitors, and practical considerations for matching treatment decisions to patient goals, access, safety, and long-term adherence. Presenters: Srikanth Muppidi, MD Clinical Professor Department of Neurology and Neurological Sciences Stanford University Stanford, California Pushpa Narayanaswami, MD, FAAN Professor of Clinical Neurology Harvard Medical School Vice Chair, Clinical Operations Department of Neurology Beth Israel Deaconess Medical Center Boston, Massachusetts Henry J. Kaminski, MD Jeffrey Lieberman Professor of Neurosciences Professor of Neurology, Pharmacology & Physiology George Washington University Principal Investigator, MGNet Rare Disease Clinical Research Consortium Washington, DC Pritikanta Paul, MD Assistant Professor of Neurology University of California, San Francisco Co-Director, MG Clinic San Francisco, California Link to full program: https://bit.ly/4aXq3Ce Get access to all of our new podcasts by subscribing to the Decera Clinical Education Neuroscience Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Multiple sclerosis care is evolving fast, from what current AAN guidance emphasizes to what’s emerging in the treatment pipeline. In this episode, Patricia K. Coyle, MD, FAAN, FANA, reviews practical, patient-centered principles for MS management, including shared decision-making, realistic expectations, adherence, monitoring, and optimizing comorbidities and lifestyle factors. She also explains when to reassess and potentially switch therapy based on relapses, disability progression, and MRI activity, and highlights pipeline advances such as CNS-penetrant BTK inhibitors and other investigational approaches. Presenters:Patricia K. Coyle, MD, FAAN, FANA Distinguished Professor of Neurology Vice Chair for Academic Affairs Department of Neurology Stony Brook Renaissance School of Medicine Director, MS Comprehensive Care Center Stony Brook, New York Link to full program:https://bit.ly/4dhvLAL Get access to all of our new podcasts by subscribing to the Decera Clinical Education Neuroscience Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Wondering what is coming next in MS care beyond today’s disease-modifying therapies? This episode spotlights CNS-penetrant oral BTK inhibitors and the fast-moving pipeline targeting neuroinflammation, immune reset, and future CNS repair, then brings it to life with a real patient case that tests treatment selection and the decision to switch therapy. Led by Patricia K. Coyle, MD, FAAN, FANA, it is a practical listen for healthcare professionals who want a clear sense of where MS treatment is heading and why it matters now. Presenters: Patricia K. Coyle, MD, FAAN, FANA Distinguished Professor of Neurology Vice Chair for Academic Affairs Department of Neurology Stony Brook Renaissance School of Medicine Director, MS Comprehensive Care Center Stony Brook, New York Link to full program:https://bit.ly/4sau7px Get access to all of our new podcasts by subscribing to the Decera Clinical Education Neuroscience Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Multiple sclerosis (MS) is increasingly understood as a spectrum in which relapsing activity and progression can overlap, creating a need for smart, individualized use of disease-modifying therapies. Listen in to learn from Patricia K. Coyle, MD, FAAN, FANA, for a practical review of today’s MS DMT options, with a focus on high-efficacy monoclonal antibodies such as anti-CD20 therapies, how healthcare professionals think about progression concepts like PIRA and RAW, and what emerging trial designs like OCTOPUS may mean for improving treatment options in progressive MS. Presenter: Patricia K. Coyle, MD, FAAN, FANA Distinguished Professor of Neurology Vice Chair for Academic Affairs Department of Neurology Stony Brook Renaissance School of Medicine Director, MS Comprehensive Care Center Stony Brook, New York Link to full program:https://bit.ly/3PdRks4 Get access to all of our new podcasts by subscribing to the Decera Clinical Education Neuroscience Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this podcast episode, Dr Jonathan Meyer answers additional questions from learners at our Psychopharmacology Update conference. Questions explore other disease states where psychosis can occur, practical considerations around special populations, tolerability, drug combinations, and the potential future of muscarinic-based therapies. For additional activities in this program including a ClinicalThought commentary, a CME/CE/CPE certified on-demand webcast and a downloadable slideset, go to: https://bit.ly/4qjcYcj Faculty: Jonathan M. Meyer, MD, DLFAPA Voluntary Clinical Professor of Psychiatry University of California, San Diego Senior Academic Adviser California Department of State Hospitals San Diego, California Get access to all of our new podcasts by subscribing to the CCO Neuroscience Podcast on Apple Podcasts, YouTube Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of “Cognitive Conversations,” expert faculty discuss breaking data presentations from the 2026 Clinical Trials on Alzheimer’s Disease conference held in San Diego, California, from December 1-4, 2025, and their implications for clinical practice. Topics covered include: Evoke and evoke+ phase III trials of semaglutideSubcutaneous lecanemab as initiation and maintenance treatmentBlood-based biomarker assaysTrontinemab and other brain shuttlesTau targeting therapies in developmentPreventive impact of BCG and herpes zoster vaccinationThis podcast episode is part of the CME/CE-accredited program, “Early Clues, Lasting Impact: Detecting and Treating Alzheimer’s Disease in Its Earliest Stages,” supported by an educational grant from Novo Nordisk.  Faculty: Anton P. Porsteinsson, MD  William B. and Sheila Konar Professor of Psychiatry, Neurology, and Neuroscience, and Medicine Director, Alzheimer's Disease Care, Research and Education Program (AD-CARE) University of Rochester School of Medicine and Dentistry Rochester, New York Vijay K. Ramanan, MD, PhD Consultant and Associate Professor Director, Alzheimer’s Disease Treatment Clinic Department of Neurology Mayo Clinic Rochester, Minnesota  Link to obtain CME/CE credit:  https://bit.ly/4999otE Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this podcast episode, epilepsy specialists Danielle Becker, MD, MS, FAES, and Sarah Weatherspoon, MD, discuss the personalization of the most recently available epilepsy rescue treatments for younger kids and their implementation by the patient care team. Faculty: Danielle Becker, MD, MS, FAES  Division Director of Epilepsy Associate Professor of Neurology The Ohio State University Wexner Medical Center Columbus, Ohio  Sarah Weatherspoon, MD Associate Chief of Child Neurology Tuberous Sclerosis Center of Excellence, Neurology Co-Director Le Bonheur Children's Hospital University of Tennessee Health Science Center Memphis, Tennessee Resources mentioned in this episode: Epilepsy Foundation Seizure Action Plan ToolkitCDC Managing Epilepsy Well (MEW) NetworkLink to Brain Health Hub with additional educational activities:  https://bit.ly/3Y12Isx Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Alireza Atri, MD, PhD, discusses his approach to patient conversations on brain health and provides advice to healthcare professionals practicing in community neurology settings, in a dialogue with Robin Martinez, a patient advocate from the Smart Patients online community. Supported by an educational grant from Lilly. Faculty: Alireza Atri, MD, PhD  Chief Medical Officer, Banner Research Phoenix, Tucson and Sun City, Arizona Director, Banner Sun Health Research Institute Sun City, Arizona Robin Martinez Patient Advocate Coordinator of Online Communities Website Administration Smart Patients Inc. Denver, Colorado Resources mentioned in this episode: Alzheimer’s Association: DETeCD-ADRD Clinical Practice Guidelines for Specialty Care  https://bit.ly/4kqtYt5American Geriatrics Society: 2023 Beers Criteria for Potentially Inappropriate Medication Use in Older Adults  https://bit.ly/44zN8qGMoCA (Montreal Cognitive Assessment) : [Link to: https://mocacognition.com/]Link to obtain CME/CE credit:  https://bit.ly/44khuP5 Link to Brain Health Hub with additional educational activities: https://bit.ly/4kziu6T Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, dementia expert Anton Porsteinsson, MD, discusses his approach to conversations on brain health with patients and provides guidance for HCPs practicing in community psychiatry settings, in a dialogue with Robin Martinez, a patient advocate from the Smart Patients online community. Supported by an educational grant from Lilly. Faculty: Anton P. Porsteinsson, MD  William B. and Sheila Konar Professor of Psychiatry, Neurology, Neuroscience, and Medicine Director, Alzheimer’s Disease Care, Research and Education Program (AD-CARE) University of Rochester School of Medicine and Dentistry Rochester, New York Robin Martinez Patient Advocate Coordinator of Online Communities Website Administration Smart Patients Inc. Denver, Colorado Resources mentioned in this episode: Mini Mental State Examination (MMSE) [Link to: https://www.psychdb.com/_media/mmse.]Mini-Cog (quick dementia screening test) [Link to: https://mini-cog.com/]MoCA (Montreal Cognitive Assessment) : [Link to: https://mocacognition.com/]Alzheimer’s Association Local Chapters [Link to:https://www.alz.org/chapter-search]Local Department of Aging [Link to : https://www.thecountyoffice.com/department-of-aging/]Link to obtain CME/CE credit:  https://bit.ly/3IAbyc7 Link to Brain Health Hub with additional educational activities:  https://bit.ly/40Jgth4   Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Genevieve Neal-Perry, MD, PhD, discusses her approach to conversations on brain health with her patients in obstetrics and gynecology settings, in a dialogue with Robin Martinez, a patient advocate from the Smart Patients online community. Supported by an educational grant from Lilly. Faculty: Genevieve Neal-Perry, MD, PhD  Robert A. Ross Distinguished Professor Chair of Obstetrics and Gynecology University of North Carolina School of Medicine Chapel Hill, North Carolina Robin Martinez Patient Advocate Coordinator of Online Communities Website Administration Smart Patients Inc. Denver, Colorado Resources mentioned in this episode: Smart Patients, an online community for patients and their families [Link to: https://www.smartpatients.com/]Link to obtain CME/CE credit:  https://bit.ly/4lH4BEt Link to Brain Health Hub with additional educational activities: https://bit.ly/4nJrgSG Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Pierre N. Tariot, MD, discusses his approach to conversations on brain health with his patients and their family members in primary care settings, in a dialogue with Robin Martinez, a patient advocate from the Smart Patients online community. Supported by an educational grant from Lilly. Faculty: Pierre N. Tariot, MD Director Banner Alzheimer's Institute Research Professor of Psychiatry University of Arizona College of Medicine Phoenix, Arizona Robin Martinez Patient Advocate Coordinator of Online Communities Website Administration Smart Patients Inc. Denver, Colorado Resources mentioned in this episode: Banner Alzheimer InstituteECHO (Extension for Community Healthcare Outcomes)MoCA (Montreal Cognitive Assessment)Mini-Cog (quick dementia screening test)FDA Clears First Blood Test Used in Diagnosing Alzheimer’s DiseaseLancet Commission: Dementia Prevention, Intervention, and Care 2024Link to obtain CME/CE credit: https://bit.ly/4kk1vFs Link to Brain Health Hub with additional educational activities: https://bit.ly/3H4hoSl Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Susan Scanland, MSN, CRNP, GNP-BC, CDP, discusses her approach to conversations on brain health with her patients and their family members in clinical practice as a gerontological nurse practitioner, in a dialogue with Robin Martinez, a patient advocate from the Smart Patients online community. Supported by an educational grant from Lilly. Faculty: Susan Scanland, MSN, CRNP, GNP-BC, CDP CEO & Founder Dementia Connection LLC Clarks Summit, PennsylvaniaRobin Martinez Patient Advocate Coordinator of Online Communities Website Administration Smart Patients Inc. Denver, ColoradoResources mentioned in this episode: Alzheimer’s Association: 2025 Alzheimer’s Disease Facts and FiguresLancet Commission: Dementia Prevention, Intervention, and Care 2024American Geriatrics Society: 2023 Beers Criteria for Potentially Inappropriate Medication Use in Older AdultsAlzheimer’s Association: DETeCD-ADRD Clinical Practice Guidelines for Primary CareClinical Care Options: Integrating Brain Health Discussions Into Your Daily RoutineLink to obtain CME/CE credit: https://bit.ly/4mqHoaS Link to Brain Health Hub with additional educational activities: https://bit.ly/3H4hoSl Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.